an expected and timely partnership for distribution in the USA should be imminent and should lead to increasing quarterly revenues. That will propel this company as an Aussie bio with revenue increasing and other potentials in the pipeline.
Ortho-ACL (Rope), page-19
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $77.54M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.3¢ | 37.0¢ | $8.069K | 21.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 32843 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 35726 | 1 |
View Market Depth
| Last trade - 12.41pm 28/08/2024 (20 minute delay) ? |
| OCC (ASX) Chart |